Dr. Peles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Florida Cancer Specialists (JFK)
4801 S Congress Ave, Suite 400
Lake Worth, FL 33461Phone+1 561-366-4100Fax+1 855-280-3692
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2003 - 2006
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2000 - 2003
- University of the WitwatersrandClass of 1998
Certifications & Licensure
- FL State Medical License 2006 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Publications & Presentations
PubMed
- 205 citationsTargeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.Ariela Noy, Sven de Vos, Catherine Thieblemont, Peter Martin, Christopher R. Flowers
Blood. 2017-04-20 - 63 citationsDurable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.Ariela Noy, Sven de Vos, Morton Coleman, Peter Martin, Christopher R. Flowers
Blood Advances. 2020-11-24 - 30 citationsEffects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesiaAdrian Miranda, Shachar Peles, Peter G. McLean, Jyoti N. Sengupta
Pain. 2006-12-15
Press Mentions
- Living with A Rare Blood Cancer, Polycythemia VeraOctober 28th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: